Literature DB >> 23881913

Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6.

Rongya Tao1, Xiwen Xiong, Ronald A DePinho, Chu-Xia Deng, X Charlie Dong.   

Abstract

Cholesterol homeostasis is crucial for cellular function and organismal health. The key regulator for the cholesterol biosynthesis is sterol-regulatory element binding protein (SREBP)-2. The biochemical process and physiological function of SREBP-2 have been well characterized; however, it is not clear how this gene is epigenetically regulated. Here we have identified sirtuin (Sirt)6 as a critical factor for Srebp2 gene regulation. Hepatic deficiency of Sirt6 in mice leads to elevated cholesterol levels. On the mechanistic level, Sirt6 is recruited by forkhead box O (FoxO)3 to the Srebp2 gene promoter where Sirt6 deacetylates histone H3 at lysines 9 and 56, thereby promoting a repressive chromatin state. Remarkably, Sirt6 or FoxO3 overexpression improves hypercholesterolemia in diet-induced or genetically obese mice. In summary, our data suggest an important role of hepatic Sirt6 and FoxO3 in the regulation of cholesterol homeostasis.

Entities:  

Keywords:  epigenetics; forkhead box O3 transcription factor; gene regulation; histone acetylation; sirtuin 6; sterol-regulatory element binding protein 2; transcription

Mesh:

Substances:

Year:  2013        PMID: 23881913      PMCID: PMC3770087          DOI: 10.1194/jlr.M039339

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  69 in total

1.  Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.

Authors:  Shan-Shan Yu; Yi Cai; Jian-Tao Ye; Rong-Biao Pi; Shao-Rui Chen; Pei-Qing Liu; Xiao-Yan Shen; Yong Ji
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

2.  Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice.

Authors:  Cuiying Xiao; Rui-Hong Wang; Tyler J Lahusen; Ogyi Park; Adeline Bertola; Takashi Maruyama; Della Reynolds; Qiang Chen; Xiaoling Xu; Howard A Young; Wan-Jun Chen; Bin Gao; Chu-Xia Deng
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

3.  Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin.

Authors:  Lihua Min; Yuan Ji; Latifa Bakiri; Zhixin Qiu; Jin Cen; Xiaotao Chen; Lingli Chen; Harald Scheuch; Hai Zheng; Lunxiu Qin; Kurt Zatloukal; Lijian Hui; Erwin F Wagner
Journal:  Nat Cell Biol       Date:  2012-10-07       Impact factor: 28.824

Review 4.  Expanding roles for SREBP in metabolism.

Authors:  Wei Shao; Peter J Espenshade
Journal:  Cell Metab       Date:  2012-09-20       Impact factor: 27.287

5.  SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span.

Authors:  Tiara L A Kawahara; Eriko Michishita; Adam S Adler; Mara Damian; Elisabeth Berber; Meihong Lin; Ron A McCord; Kristine C L Ongaigui; Lisa D Boxer; Howard Y Chang; Katrin F Chua
Journal:  Cell       Date:  2009-01-09       Impact factor: 41.582

Review 6.  FoxO1 integrates insulin signaling to VLDL production.

Authors:  Adama Kamagate; H Henry Dong
Journal:  Cell Cycle       Date:  2008-10-27       Impact factor: 4.534

7.  Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner.

Authors:  Frédéric Van Gool; Mara Gallí; Cyril Gueydan; Véronique Kruys; Pierre-Paul Prevot; Antonio Bedalov; Raul Mostoslavsky; Frederick W Alt; Thibaut De Smedt; Oberdan Leo
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

8.  The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses.

Authors:  Inga Bauer; Alessia Grozio; Denise Lasigliè; Giovanna Basile; Laura Sturla; Mirko Magnone; Giovanna Sociali; Debora Soncini; Irene Caffa; Alessandro Poggi; Gabriele Zoppoli; Michele Cea; Georg Feldmann; Raul Mostoslavsky; Alberto Ballestrero; Franco Patrone; Santina Bruzzone; Alessio Nencioni
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

9.  The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun.

Authors:  Nagalingam R Sundaresan; Prabhakaran Vasudevan; Lei Zhong; Gene Kim; Sadhana Samant; Vishwas Parekh; Vinodkumar B Pillai; P V Ravindra; Madhu Gupta; Valluvan Jeevanandam; John M Cunningham; Chu-Xia Deng; David B Lombard; Raul Mostoslavsky; Mahesh P Gupta
Journal:  Nat Med       Date:  2012-10-21       Impact factor: 53.440

10.  C. elegans SIRT6/7 homolog SIR-2.4 promotes DAF-16 relocalization and function during stress.

Authors:  Wei-Chung Chiang; Daniel X Tishkoff; Bo Yang; Joshua Wilson-Grady; Xiaokun Yu; Travis Mazer; Mark Eckersdorff; Steven P Gygi; David B Lombard; Ao-Lin Hsu
Journal:  PLoS Genet       Date:  2012-09-13       Impact factor: 5.917

View more
  59 in total

1.  Hepatocyte-specific Sirt6 deficiency impairs ketogenesis.

Authors:  Lei Chen; Qinhui Liu; Qin Tang; Jiangying Kuang; Hong Li; Shiyun Pu; Tong Wu; Xuping Yang; Rui Li; Jinhang Zhang; Zijing Zhang; Ya Huang; Yanping Li; Min Zou; Wei Jiang; Tao Li; Meng Gong; Lu Zhang; Hua Wang; Aijuan Qu; Wen Xie; Jinhan He
Journal:  J Biol Chem       Date:  2018-12-10       Impact factor: 5.157

Review 2.  SIRT6, a Mammalian Deacylase with Multitasking Abilities.

Authors:  Andrew R Chang; Christina M Ferrer; Raul Mostoslavsky
Journal:  Physiol Rev       Date:  2019-08-22       Impact factor: 37.312

3.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

Review 4.  SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection.

Authors:  Nunzia D'Onofrio; Luigi Servillo; Maria Luisa Balestrieri
Journal:  Antioxid Redox Signal       Date:  2017-06-29       Impact factor: 8.401

5.  Sirtuin 6 regulates glucose-stimulated insulin secretion in mouse pancreatic beta cells.

Authors:  Xiwen Xiong; Gaihong Wang; Rongya Tao; Pengfei Wu; Tatsuyoshi Kono; Kevin Li; Wen-Xing Ding; Xin Tong; Sarah A Tersey; Robert A Harris; Raghavendra G Mirmira; Carmella Evans-Molina; X Charlie Dong
Journal:  Diabetologia       Date:  2016-01       Impact factor: 10.122

6.  The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice.

Authors:  Hyeong Geug Kim; Menghao Huang; Yue Xin; Yang Zhang; Xinge Zhang; Gaihong Wang; Sheng Liu; Jun Wan; Ali Reza Ahmadi; Zhaoli Sun; Suthat Liangpunsakul; Xiwen Xiong; Xiaocheng Charlie Dong
Journal:  J Hepatol       Date:  2019-07-08       Impact factor: 25.083

7.  Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity.

Authors:  Deqiang Zhang; Xin Tong; Kyle VanDommelen; Neil Gupta; Kenneth Stamper; Graham F Brady; Zhuoxian Meng; Jiandie Lin; Liangyou Rui; M Bishr Omary; Lei Yin
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

8.  FOXO transcription factors in non-alcoholic fatty liver disease.

Authors:  X Charlie Dong
Journal:  Liver Res       Date:  2017-09

Review 9.  Chromatin and beyond: the multitasking roles for SIRT6.

Authors:  Sita Kugel; Raul Mostoslavsky
Journal:  Trends Biochem Sci       Date:  2014-01-14       Impact factor: 13.807

Review 10.  Non-coding RNAs: the new central dogma of cancer biology.

Authors:  Phei Er Saw; Xiaoding Xu; Jianing Chen; Er-Wei Song
Journal:  Sci China Life Sci       Date:  2020-09-11       Impact factor: 6.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.